Form 4: Zomedica Corp. COO Anthony K. Blair Reports Acquisition of 100,000 Shares
SEC Form 4
Zomedica Corp.'s COO, Anthony K. Blair, reports the acquisition of 100,000 shares of common stock through open market purchases.
Summary
- On May 21, 2025, Anthony K. Blair, the COO of Zomedica Corp., acquired 36,250 shares of common stock at $0.049 per share.
- He also acquired 63,750 shares of common stock at $0.05 per share on the same day.
- Following these transactions, Blair directly owns 1,000,000 shares of Zomedica Corp. common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The COO's purchase of shares is a positive signal, but the overall impact is limited without more context.
Positives
- The COO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company insider believes the stock is undervalued. However, it's important to consider the overall context and not rely solely on insider trading activity when making investment decisions.
Stakeholder Impact
- The stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of stock acquisition by Anthony K. Blair |
Keywords
Zomedica Corp, insider trading, Anthony K. Blair, ZOMDF, COO, stock acquisition, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.